| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/27/2004 | US6767917 Diuretics; cardiovascular, kidney and brain disorder treatment; antitumor, antiallergen, and antiasthmatic agents |
| 07/27/2004 | US6767901 Ciclesonide contained pharmaceutical composition for application to mucosa |
| 07/27/2004 | US6767899 Composition and method for treatment of conditions having an inflammatory component |
| 07/27/2004 | US6767892 Insulin-like growth factor-1 is solubilized with guanidinium compound |
| 07/27/2004 | US6767743 Method and an apparatus for generating shockwave, a method and an apparatus for accelerating particles, an apparatus for delivering drugs, and a method and an apparatus for delivering DNA |
| 07/27/2004 | US6767567 Ingestible elements |
| 07/27/2004 | US6767559 DASC compositions, process for preparing same and suspensions containing same |
| 07/27/2004 | US6767558 Adding to a pharmaceutical formulation susceptible to oxidation, an oxidation-inhibiting amount of a ferrous ion source, preferably in the form of an excipient |
| 07/27/2004 | US6767557 Taste masked pharmaceutical compositions |
| 07/27/2004 | US6767556 Hypotensive agents |
| 07/27/2004 | US6767555 A cyclosporin-containing composition in the form of a capsule consists of a polyoxyethylene sorbitan fatty acid ester, a reaction product of a natural or hydrogenated castor oil, ethylene oxide, a sorbitan fatty ester, and ethanol |
| 07/27/2004 | US6767554 Use of complexes among cationic liposomes and polydeoxyribonucleotides and medicaments |
| 07/27/2004 | US6767552 Adhesive treatment for oral fungal infection |
| 07/27/2004 | US6767550 Hydroxyapatite based drug delivery implant for cancer treatment |
| 07/27/2004 | US6767507 Uncomplexed cyclodextrin compositions for odor control |
| 07/27/2004 | US6767483 Sonicating aqueous solution of phospholipid to form solution of multilamellar vesicles, freezing and thawing solution, filtering to form solution of small unilamellar vesicles, curing; for renal dialysis |
| 07/27/2004 | US6767247 Coaxial connector having detachable locking sleeve |
| 07/27/2004 | US6767200 Systems, methods and apparatuses for manufacturing dosage forms |
| 07/27/2004 | US6766680 Determination of gas solubility, entrained gas content, and true liquid density in manufacturing processes |
| 07/27/2004 | CA2358395C Extended release formulations of erythromycin derivatives |
| 07/27/2004 | CA2061692C Ceramides; process for preparing the same and their use as cosmetic and skin pharmaceutical agents |
| 07/27/2004 | CA2056371C Stable microbubbles suspensions injectable into living organisms |
| 07/22/2004 | WO2004061457A1 Organic inorganic hybrid material, method for the production thereof |
| 07/22/2004 | WO2004061433A1 Pharmaceutical compositions with improved dissolution |
| 07/22/2004 | WO2004061043A1 Spraying composition |
| 07/22/2004 | WO2004060977A1 Multi-arm polypeptide-poly(ethylene glycol) block copolymers as drug delivery vehicles |
| 07/22/2004 | WO2004060903A2 Aerosolizable pharmaceutical formulation for fungal infection therapy |
| 07/22/2004 | WO2004060899A1 Phospholipid derivatives and process for the production there |
| 07/22/2004 | WO2004060878A2 Inhibitors of phosphatases |
| 07/22/2004 | WO2004060791A1 Peptide nanostructures encapsulating a foreign material and method of manufacturing same |
| 07/22/2004 | WO2004060626A1 Pelletizing yew biomass for extraction of taxanes and other natural products |
| 07/22/2004 | WO2004060547A1 Methods and apparatus for making particles using spray dryer and in-line jet mill |
| 07/22/2004 | WO2004060473A2 Active agent delivery device having composite members |
| 07/22/2004 | WO2004060447A2 Transdermal delivery using encapsulated agent activated by ultrasound and/or heat |
| 07/22/2004 | WO2004060443A2 Apparatuses and methods for automatically assessing and monitoring a patient’s responsiveness |
| 07/22/2004 | WO2004060402A1 Method and material for specific proliferation promotion of lymphocyte sub-populations by means of a combination of an immunomodulator with a non-water-soluble natural product and a carrier |
| 07/22/2004 | WO2004060401A1 Compositions, methods, and kits useful for the alleviation of gastrointestinal side effects of lipase inhibitors |
| 07/22/2004 | WO2004060396A2 Immunogenic compositions containing phospholpid |
| 07/22/2004 | WO2004060387A1 Compositions and methods for the prevention and control of insulin-induced hypoglycemia |
| 07/22/2004 | WO2004060385A1 Ophthalmic therapeutic composition |
| 07/22/2004 | WO2004060379A2 Pharmaceutical compositions comprising an antibacterial agent nd antifungal agent and a nitroimidazole for the treatment and prevention of genitourinary infections and their extragenital complications |
| 07/22/2004 | WO2004060378A2 Compositions comprising particles containing alumina with compounds bound to the alumina surface, delivery systems and methods of preparation thereof |
| 07/22/2004 | WO2004060372A1 Dosage forms containing a proton pump inhibitor, a nsaid, and a buffer |
| 07/22/2004 | WO2004060363A1 Method for producing sterile polynucleotide based medicaments |
| 07/22/2004 | WO2004060358A2 Method of encapsulating an active lipid-soluble substance by preparing a pit emulsion and emulsion obtained |
| 07/22/2004 | WO2004060357A1 Acid labile drug compositions |
| 07/22/2004 | WO2004060356A1 Use of thickening agents for producing soft capsules and film production method |
| 07/22/2004 | WO2004060355A1 Multilayer Dosage Forms Containing NSAIDs and Triptans |
| 07/22/2004 | WO2004060354A1 Methods for making pharmaceutical dosage forms containing active cushioning components |
| 07/22/2004 | WO2004060353A1 Solid dispersions comprising a hygroscopic and/or deliquescent drug |
| 07/22/2004 | WO2004060352A1 Non-hygroscopic formulation comprising a hydroscopic drug |
| 07/22/2004 | WO2004060351A2 Pharmaceutical formulation with an insoluble active agent for pulmonary administration |
| 07/22/2004 | WO2004060350A1 Immobilisation of dna-labelled lipid vesicles on dna arrays |
| 07/22/2004 | WO2004060349A1 Emulsions including surface-modified inorganic nanoparticles |
| 07/22/2004 | WO2004060348A2 Ophthalmic and ophthalmological use of a complex nutritive base in an aqueous medium |
| 07/22/2004 | WO2004060347A2 Pharmaceutical propylene glycol solvate compositions |
| 07/22/2004 | WO2004060346A2 Drug delivery from rapid gelling polymer composition |
| 07/22/2004 | WO2004060345A2 Dispersible pharmaceutical compositions |
| 07/22/2004 | WO2004060344A2 Methods for making pharmaceutical formulations comprising deagglomerated microparticles |
| 07/22/2004 | WO2004060343A1 Antibody-containing particles and compositions |
| 07/22/2004 | WO2004060342A1 Nutritional supplement composition and method |
| 07/22/2004 | WO2004060315A2 Stable topical drug delivery compositions |
| 07/22/2004 | WO2004060303A2 Methods and reagents for the enhancement of virus transduction in the bladder epithelium |
| 07/22/2004 | WO2004060298A2 Fast dissolving films for oral administration of drugs |
| 07/22/2004 | WO2004060278A2 Methods for rapid identification of pathogens in humans and animals |
| 07/22/2004 | WO2004060268A2 A method and article to control cellulite |
| 07/22/2004 | WO2004060266A2 Eye-drop vaccine containing copolymer poly-ye for therapeutic immunization |
| 07/22/2004 | WO2004060265A2 Eye-drop vaccine containing copolymer 1 for therapeutic immunization |
| 07/22/2004 | WO2004060198A1 Coated micromesh dental devices overcoated with imbedded particulate |
| 07/22/2004 | WO2004060075A1 Substance for creating a saturation effect and reducing weight in animals |
| 07/22/2004 | WO2004060059A2 Method for freeze-drying nucleic acid/block copolymer/cationic surfactant complexes |
| 07/22/2004 | WO2004052420A3 Barriers for bioactive agent-containing polymeric coatings |
| 07/22/2004 | WO2004041324A3 Transdermal delivery of fentanyl |
| 07/22/2004 | WO2004041118A3 Therapeutic compositions for drug delivery to and through covering epithelia |
| 07/22/2004 | WO2004039817A9 Cardiolipin molecules and method of synthesis |
| 07/22/2004 | WO2004037203A9 Sustained release l-arginine formulations and methods of manufacture and use |
| 07/22/2004 | WO2004037187A8 Metal-containing materials, compositions and methods |
| 07/22/2004 | WO2004034963A3 Methods and compositions using cholinesterase inhibitors |
| 07/22/2004 | WO2004032897A8 Pharmaceutical preparations, use of said preparations and method for increasing the bioavailability of medicaments for peroral administration |
| 07/22/2004 | WO2004027044A3 Triplex hairpin ribozyme |
| 07/22/2004 | WO2004024126B1 Capsules containing aqueous fill compositions stabilized with derivatized cyclodextrin |
| 07/22/2004 | WO2004016286A3 Pharmaceutical anti-tnf-alpha antibody formulation |
| 07/22/2004 | WO2004011055A3 Implantable or insertable medical devices for controlled drug delivery |
| 07/22/2004 | WO2003106382A3 Reversed liquid crystalline phases with non-paraffin hydrophobes |
| 07/22/2004 | WO2003104283A3 Polymeric surfactant compositions and methods of manufacture and use |
| 07/22/2004 | WO2003097007A3 Aqueous ophthalmic composition comprising a lyotropic mesomorphic lipid |
| 07/22/2004 | WO2003094886A3 Desmopressin in an orodispersible dosage form |
| 07/22/2004 | WO2003051398A8 Parenteral composition of paracetamol |
| 07/22/2004 | WO2003022869A3 Human immunodeficiency virus envelope clycoprotein mutants and uses thereof |
| 07/22/2004 | WO2003017919A3 Composition comprising wenguanguo extracts, methods for preparing same and uses therof |
| 07/22/2004 | WO2003014296A3 A group of novel anti-cancer compounds with specific structure |
| 07/22/2004 | WO2003006002A9 Compositions and methods of administering tubulin binding agents for the treatment of ocular diseases |
| 07/22/2004 | WO2002094002A3 Cultivated agarwood |
| 07/22/2004 | US20040143329 compressive modulus of elasticity of 0.1 - 10 megapascals, and a glass transition temperature greater than 40 degrees C.; especially for tissue replacement, tissue scaffolding or a low bearing surface within a joint |
| 07/22/2004 | US20040143242 Troubleshooting accelerator system for implantable drug delivery pumps |
| 07/22/2004 | US20040143236 Thermally-activated reservoir devices |
| 07/22/2004 | US20040143026 Bioadhesive hydrophilic composition for treatment of mammalian skin |
| 07/22/2004 | US20040143019 Sustained release suppositories; for chelate therapy |
| 07/22/2004 | US20040143012 Retinoids; bioavailability; mouth administering |
| 07/22/2004 | US20040143005 Colon cleansing compositions and methods |